📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders. (2018)

First Author: Scheffler F

Attributed to: Methylomic profiling in schizophrenia: towards an integrated genetic-epigenetic approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2018.02.050

PubMed Identifier: 29519756

Publication URI: http://europepmc.org/abstract/MED/29519756

Type: Journal Article/Review

Volume: 199

Parent Publication: Schizophrenia research

ISSN: 0920-9964